Convection enhanced delivery

A method for targeted drug delivery in the brain

Convection-enhanced delivery (CED) is a technique used to deliver therapeutic agents directly into the brain tissue. This method is particularly useful for treating brain tumors and other central nervous system disorders. CED involves the use of a pressure gradient to infuse drugs into the interstitial spaces of the brain, allowing for a more uniform distribution of the therapeutic agent compared to traditional diffusion-based methods.

Mechanism of Action

CED works by creating a pressure gradient that drives the therapeutic agent through the extracellular space of the brain tissue. This is achieved by inserting a catheter into the brain and using a pump to deliver the drug at a controlled rate. The pressure gradient ensures that the drug is distributed over a larger volume of tissue, which can enhance the therapeutic effect and reduce systemic toxicity.

Glioblastoma Treatment Using CED

Catheter Design

The design of the catheter is crucial for the success of CED. Catheters used in CED are typically flexible and have multiple ports to allow for even distribution of the drug. Recent advances in catheter technology have led to the development of novel designs that minimize backflow and improve the precision of drug delivery.

Novel Catheter Designs for Use with CED

Applications

CED is primarily used in the treatment of glioblastoma, a highly aggressive form of brain cancer. By delivering chemotherapeutic agents directly to the tumor site, CED can increase the concentration of the drug in the tumor while minimizing exposure to the rest of the body. This targeted approach can improve treatment outcomes and reduce side effects.

In addition to cancer treatment, CED is being explored for the delivery of therapeutic agents in neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. The ability to bypass the blood-brain barrier makes CED an attractive option for delivering large molecules that would otherwise be unable to reach the brain tissue.

Challenges and Limitations

Despite its potential, CED faces several challenges. One of the main limitations is the difficulty in predicting the distribution of the drug within the brain tissue. Factors such as tissue heterogeneity and the presence of barriers within the brain can affect the spread of the therapeutic agent. Additionally, the invasive nature of the procedure poses risks such as infection and hemorrhage.

Future Directions

Research is ongoing to improve the efficacy and safety of CED. Advances in imaging techniques, such as magnetic resonance imaging (MRI), are being used to monitor drug distribution in real-time, allowing for adjustments to be made during the procedure. Furthermore, the development of new therapeutic agents that are specifically designed for use with CED could enhance the effectiveness of this delivery method.

Related Pages

• Drug delivery
• Blood-brain barrier
• Glioblastoma
• Neurodegenerative disease